Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Metastatic Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Testing effectiveness (Phase 2)Study completedNCT00711243
What this trial is testing

Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor

Who this might be right for
Gastric CancerUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 59
Early research (Phase 1)Study completedNCT03010176
What this trial is testing

Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)

Who this might be right for
Solid TumorsLymphoma
Merck Sharp & Dohme LLC 156
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Early research (Phase 1)Looking for participantsNCT06349408
What this trial is testing

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Fortvita Biologics (USA)Inc. 250
Testing effectiveness (Phase 2)Study completedNCT05661578
What this trial is testing

Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors

Who this might be right for
PD-L1-selected Solid Tumors
Hoffmann-La Roche 64
Early research (Phase 1)Looking for participantsNCT07705035
What this trial is testing

DBC-664 in Adult Patients With Solid Tumors

Who this might be right for
Malignant Germ Cell TumorLung AdenocarcinomaGastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma+3 more
Duboce Biopharmaceuticals, Inc. 210
Early research (Phase 1)Ended earlyNCT04021277
What this trial is testing

PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin

Who this might be right for
Solid TumorColorectal Cancer
EXACT Therapeutics AS 11
Large-scale testing (Phase 3)Looking for participantsNCT03805022
What this trial is testing

Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas

Who this might be right for
Non-metastatic Soft-tissue SarcomaResectable
Institut Bergonié 351
Testing effectiveness (Phase 2)Looking for participantsNCT06616766
What this trial is testing

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Solid Tumor
Yuhan Corporation 201
Early research (Phase 1)Study completedNCT00128622
What this trial is testing

Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
H. Kim Lyerly 24
Very early researchStudy completedNCT07299253
What this trial is testing

Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06

Who this might be right for
Metastatic Solid Tumors (Any Localization)
Lanzhou University Second Hospital 5
Early research (Phase 1)UnknownNCT05420545
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 36
Early research (Phase 1)Looking for participantsNCT07288957
What this trial is testing

A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumors (Phase 1)
Abbisko Therapeutics Co, Ltd 266
Early research (Phase 1)WithdrawnNCT03612466
What this trial is testing

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Who this might be right for
OsteosarcomaBone Metastases
Albert Einstein College of Medicine
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Looking for participantsNCT07028268
What this trial is testing

A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors

Who this might be right for
For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 210
Early research (Phase 1)Study completedNCT04261413
What this trial is testing

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S. 16
Testing effectiveness (Phase 2)Looking for participantsNCT05379985
What this trial is testing

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 754
Early research (Phase 1)Ended earlyNCT04729725
What this trial is testing

SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
M.D. Anderson Cancer Center 3
Next Page